Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 624
Filter
1.
J Agric Food Chem ; 72(28): 15801-15810, 2024 Jul 17.
Article in English | MEDLINE | ID: mdl-38962874

ABSTRACT

Fungal azaphilones have attracted widespread attention due to their significant potential as sources of food pigments and pharmaceuticals. Genome mining and gene cluster activation represent powerful tools and strategies for discovering novel natural products and bioactive molecules. Here, a putative azaphilone biosynthetic gene cluster lut from the endophytic fungus Talaromyces sp. was identified through genome mining. By overexpressing the pathway-specific transcription factor LutB, five new sclerotiorin-type azaphilones (1, 6, 8, and 10-11) together with seven known analogues (2-5, 7, 9, 12) were successfully produced. Compounds 8 and 9 exhibited antibacterial activity against Bacillus subtilis with MIC values of 64 and 16 µg/mL, respectively. Compound 11 showed cytotoxic activity against HCT116 and GES-1 with IC50 values of 10.9 and 4.9 µM, respectively, while 1, 4, 5, and 7-10 showed no obvious cytotoxic activity. Gene inactivation experiments confirmed the role of the lut cluster in the production of compounds 1-12. Subsequent feeding experiments unveiled the novel functional diversity of the dual megasynthase system. Furthermore, a LutC-LutD binary oxidoreductase system was discovered, and in combination with DFT calculations, the basic biosynthetic pathway of the sclerotiorin-type azaphilones was characterized. This study provided a good example for the discovery of new azaphilones and further uncovered the biosynthesis of these compounds.


Subject(s)
Benzopyrans , Fungal Proteins , Multigene Family , Pigments, Biological , Talaromyces , Talaromyces/genetics , Talaromyces/metabolism , Talaromyces/chemistry , Pigments, Biological/chemistry , Pigments, Biological/metabolism , Humans , Benzopyrans/pharmacology , Benzopyrans/chemistry , Benzopyrans/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Fungal Proteins/chemistry , Endophytes/genetics , Endophytes/metabolism , Endophytes/chemistry , Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Cell Line, Tumor
2.
J Hazard Mater ; 476: 134947, 2024 Sep 05.
Article in English | MEDLINE | ID: mdl-38908180

ABSTRACT

Microbially-driven arsenic reduction and methane emissions in anaerobic soils are regulated by widespread humic substances (HS), while how this effect responds to climate change remains unknown. We investigated potential synergistic effects of HS in response to temperature changes in arsenic-contaminated paddy soils treated with humic acid (HA) and fulvic acid (FA) at temperatures ranging from 15 to 45 °C. Our results reveal a significant increase in arsenic reduction (5.6 times) and methane emissions (178 times) driven by HS, which can be exponentially stimulated at 45 °C. Acting as a electron shuttle, HS determines microbial arsenic reduction, further stimulated by warming. The top three sensitive genera are Geobacter, Anaeromyxobacter, and Gaiella which are responsible for enhanced arsenic reduction, as well as for the reduction of iron and HS with their functional genes; arrA and Geobacter spp. The top three sensitive methanogens are Methanosarsina, Methanocella, and Methanoculleus. Our study suggests notable synergistic effects between HS and warming in stimulating arsenic reduction and methanogenesis in paddy soils. Overall, the findings of this work highlight the high sensitivity of HS-mediated microbial arsenic transformation and methanogenesis in response to warming, which add potential value in predicting the biogeochemical cycling of arsenic and methane in soil under the context of climate change.


Subject(s)
Arsenic , Humic Substances , Methane , Soil Microbiology , Soil Pollutants , Arsenic/metabolism , Methane/metabolism , Soil Pollutants/metabolism , Oryza/metabolism , Oryza/growth & development , Benzopyrans/metabolism , Oxidation-Reduction , Floods , Climate Change , Soil/chemistry , Bacteria/metabolism , Bacteria/drug effects
3.
Chem Biodivers ; 21(8): e202400920, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38818615

ABSTRACT

Parkinson's disease (PD) is a neurodegenerative condition characterized by both motor and non-motor symptoms. Although PD is commonly associated with a decline of dopaminergic neurons in the substantia nigra, other diagnostic criteria and biomarkers also exist. In the search for novel therapeutic agents, chromene and pyran derivatives have shown potential due to their diverse pharmacological activities. This study utilizes a comprehensive computational approach to investigate the viability of chromene/pyran compounds as potential treatments for PD. The drug-likeness characteristics of these molecules were analyzed using ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies. Molecular docking was performed against PDB ID: 2V5Z. The best three molecules chosen were compound 7, compound 24, and compound 67 have a binding energy of -6.7, -8.6, and -10.9 kcal/mol. Molecules demonstrating positive blood-brain barrier permeability, good solubility, and favorable binding affinity were further evaluated using Density Functional Theory (DFT) calculations and Molecular Dynamics (MD) simulations to assess their electronic structure and stability. DFT calculations indicated that molecule 82 has a dipole moment of 15.70 D. RMSD and RMSF results confirmed the stability of the complexes over a 100 ns simulation, with a maximum of 3 hydrogen bonds formed.


Subject(s)
Benzopyrans , Density Functional Theory , Molecular Docking Simulation , Molecular Dynamics Simulation , Parkinson Disease , Pyrans , Parkinson Disease/drug therapy , Parkinson Disease/metabolism , Pyrans/chemistry , Pyrans/pharmacology , Pyrans/metabolism , Humans , Benzopyrans/chemistry , Benzopyrans/metabolism , Benzopyrans/pharmacology , Molecular Structure , Blood-Brain Barrier/metabolism , Antiparkinson Agents/chemistry , Antiparkinson Agents/pharmacology , Antiparkinson Agents/metabolism
4.
Bioresour Technol ; 403: 130857, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38763203

ABSTRACT

Immobilization technology is a promising way to improve effectiveness and stability of microbial remediation for polycyclic aromatic hydrocarbons (PAHs), in which carrier material is one of key factors restricting removal efficiency. In this study, fulvic acid-wheat straw biochar (FA/WS) composites were applied for immobilization of an efficient PAHs degrading bacterium Stenotrophomonas maltophilia (SPM). FA/WS&SPM showed superior degradation capacity than free bacteria and biochar-immobilized bacteria, with the removal efficiency of pyrene (20 mg L-1) reaching 90.5 % (7 days). Transcriptome analysis revealed that FA in the carrier materials can promote transportation and degradation of pyrene, and cell growth, as well as inhibit cell apoptosis. Enzyme activity and degradation products detection showed that SPM utilized both phthalic acid and salicylic acid metabolic pathways to degrade pyrene. Practicality of FA/WS&SPM for different kinds of PAHs remediation had been verified in contaminated soil, demonstrating a great potential in the field of PAHs polluted sites remediation.


Subject(s)
Benzopyrans , Biodegradation, Environmental , Cells, Immobilized , Pyrenes , Stenotrophomonas maltophilia , Stenotrophomonas maltophilia/metabolism , Pyrenes/metabolism , Benzopyrans/metabolism , Cells, Immobilized/metabolism , Charcoal/chemistry , Charcoal/pharmacology
5.
J Hazard Mater ; 470: 134304, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38615650

ABSTRACT

In lightly polluted water containing heavy metals, organic matter, and green microalgae, the molecular weight of organic matter may influence both the growth of green microalgae and the concentration of heavy metals. This study elucidates the effects and mechanisms by which different molecular weight fractions of fulvic acid (FA), a model dissolved organic matter component, facilitate the bioaccumulation of hexavalent chromium (Cr(VI)) in a typical green alga, Chlorella vulgaris. Findings show that the addition of FA fractions with molecular weights greater than 10 kDa significantly enhances the enrichment of total chromium and Cr(VI) in algal cells, reaching 21.58%-31.09 % and 16.17 %-22.63 %, respectively. Conversely, the efficiency of chromium enrichment in algal cells was found to decrease with decreasing molecular weight of FA. FA molecular weight within the range of 0.22 µm-30 kDa facilitated chromium enrichment primarily through the algal organic matter (AOM) pathway, with minor contributions from the algal cell proliferation and extracellular polymeric substances (EPS) pathways. However, with decreasing FA molecular weight, the AOM and EPS pathways become less prominent, whereas the algal cell proliferation pathway becomes dominant. These findings provide new insights into the mechanism of chromium enrichment in green algae enhanced by medium molecular weight FA.


Subject(s)
Benzopyrans , Chlorella vulgaris , Chromium , Microalgae , Molecular Weight , Water Pollutants, Chemical , Chromium/metabolism , Chromium/chemistry , Chlorella vulgaris/metabolism , Chlorella vulgaris/growth & development , Chlorella vulgaris/drug effects , Water Pollutants, Chemical/metabolism , Microalgae/metabolism , Microalgae/drug effects , Microalgae/growth & development , Benzopyrans/chemistry , Benzopyrans/metabolism
6.
Nat Commun ; 15(1): 3539, 2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38670975

ABSTRACT

Bergenin, a rare C-glycoside of 4-O-methyl gallic acid with pharmacological properties of antitussive and expectorant, is widely used in clinics to treat chronic tracheitis in China. However, its low abundance in nature and structural specificity hampers the accessibility through traditional crop-based manufacturing or chemical synthesis. In the present work, we elucidate the biosynthetic pathway of bergenin in Ardisia japonica by identifying the highly regio- and/or stereoselective 2-C-glycosyltransferases and 4-O-methyltransferases. Then, in Escherichia coli, we reconstruct the de novo biosynthetic pathway of 4-O-methyl gallic acid 2-C-ß-D-glycoside, which is the direct precursor of bergenin and is conveniently esterified into bergenin by in situ acid treatment. Moreover, further metabolic engineering improves the production of bergenin to 1.41 g L-1 in a 3-L bioreactor. Our work provides a foundation for sustainable supply of bergenin and alleviates its resource shortage via a synthetic biology approach.


Subject(s)
Benzopyrans , Biosynthetic Pathways , Escherichia coli , Metabolic Engineering , Benzopyrans/metabolism , Benzopyrans/chemistry , Metabolic Engineering/methods , Escherichia coli/metabolism , Escherichia coli/genetics , Glycosyltransferases/metabolism , Methyltransferases/metabolism , Gallic Acid/metabolism , Gallic Acid/chemistry , Bioreactors , Glycosides/biosynthesis , Glycosides/metabolism , Glycosides/chemistry
7.
Bioresour Technol ; 401: 130708, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38636878

ABSTRACT

In this study, the biochemical response of Phaeodactylum tricornutum to varying concentrations of inorganic selenium (Se) was investigated. It was observed that, when combined with fulvic acid, P. tricornutum exhibited enhanced uptake and biotransformation of inorganic Se, as well as increased microalgal lipid biosynthesis. Notably, when subjected to moderate (5 and 10 mg/L) and high (20 and 40 mg/L) concentrations of selenite under fulvic acid treatment, there was a discernible redirection of carbon flux towards lipogenesis and protein biosynthesis from carbohydrates. In addition, the key parameters of microalgae-based biofuels aligned with the necessary criteria outlined in biofuel regulations. Furthermore, the Se removal capabilities of P. tricornutum, assisted by fulvic acid, were coupled with the accumulation of substantial amounts of organic Se, specifically SeCys. These findings present a viable and successful approach to establish a microalgae-based system for Se uptake and biotransformation.


Subject(s)
Benzopyrans , Biofuels , Biotransformation , Diatoms , Diatoms/metabolism , Benzopyrans/metabolism , Selenious Acid/metabolism , Microalgae/metabolism
8.
Eur J Med Chem ; 262: 115878, 2023 Dec 15.
Article in English | MEDLINE | ID: mdl-37866337

ABSTRACT

A new type of benzopyrone-mediated quinolones (BMQs) was rationally designed and efficiently synthesized as novel potential antibacterial molecules to overcome the global increasingly serious drug resistance. Some synthesized BMQs effectively suppressed the growth of the tested strains, outperforming clinical drugs. Notably, ethylidene-derived BMQ 17a exhibited superior antibacterial potential with low MICs of 0.5-2 µg/mL to clinical drugs norfloxacin, it not only displayed rapid bactericidal performance and inhibited bacterial biofilm formation, but also showed low toxicity toward human red blood cells and normal MDA-kb2 cells. Mechanistic investigation demonstrated that BMQ 17a could effectually induce bacterial metabolic disorders and promote the enhancement of reactive oxygen species to disrupt the bacterial antioxidant defense system. It was found that the active molecule BMQ 17a could not only form supramolecular complex with lactate dehydrogenase, which disturbed the biological functions, but also effectively embed into calf thymus DNA, thus affecting the normal function of DNA and achieving cell death. This work would provide an insight into developing new molecules to reduce drug resistance and expand antibacterial spectrum.


Subject(s)
Anti-Bacterial Agents , Quinolones , Humans , Anti-Bacterial Agents/pharmacology , DNA Gyrase/metabolism , Microbial Sensitivity Tests , Norfloxacin/pharmacology , Quinolones/pharmacology , Quinolones/metabolism , Benzopyrans/metabolism , Benzopyrans/pharmacology
9.
J Agric Food Chem ; 71(23): 8959-8968, 2023 Jun 14.
Article in English | MEDLINE | ID: mdl-37278378

ABSTRACT

Xenocoumacin 1 (Xcn1) is an excellent antimicrobial natural product against Phytophthora capsici. However, the commercial development of Xcn1 is hindered by the low yield, which results in high application costs. In this study, multiple metabolic strategies, including blocking the degradation pathway, promoter engineering, and deletion of competing biosynthetic gene clusters, were employed to improve the production of Xcn1, which was increased from 0.07 to 0.91 g/L. The formation of Xcn1 reached 1.94 g/L in the TB medium with the final strain T3 in a shake flask and further reached 3.52 g/L in a 5 L bioreactor, which is the highest yield ever reported. The engineered strain provides a valuable platform for production of Xcn1, and the possible commercial development of the biofungicide. We anticipate that the metabolic engineering strategies utilized in this study and the constructed constitutive promoter library can be widely applied to other bacteria of the genera Xenorhabdus and Photorhabdus.


Subject(s)
Anti-Infective Agents , Xenorhabdus , Xenorhabdus/genetics , Anti-Infective Agents/metabolism , Benzopyrans/metabolism , Bioreactors/microbiology
10.
J Agric Food Chem ; 71(11): 4615-4624, 2023 Mar 22.
Article in English | MEDLINE | ID: mdl-36945879

ABSTRACT

Phaeosphaeria sp., a lichen-associated fungus, produced six skeletally new dimeric spiciferones (1-6) and four known metabolites (7-10). The new structures were elucidated by spectroscopic analysis, and their absolute configurations were determined by electronic circular dichroism calculations. Compounds 1 and 3-6 represent the first examples of ethylidene-bridged dimers from the building blocks 4H-chromene-4,7(8H)-dione and α-pyrone, and 2 is a unique homodimer of spiciferone. Compounds 1, 2, and 5-9 significantly inhibited the growth of weed-like dicot Arabidopsis thaliana at 100.0 µM. Notably, 8 showed the strongest inhibitory activity against the fresh weight and root elongation of A. thaliana with the IC50 values of 32.04 and 26.78 µM, respectively, whereas 1, 8, and 9 stimulated the growth of A. thaliana at lower concentrations. Meanwhile, compounds 2 and 6 exhibited weak inhibitory effects on the root elongation of monocot rice, while 1 and 8 exhibited growth-promoting effects on the shoot and root elongation of rice in a roughly dose-dependent manner.


Subject(s)
Arabidopsis , Ascomycota , Pyrones/chemistry , Benzopyrans/pharmacology , Benzopyrans/metabolism , Plant Growth Regulators/metabolism , Ascomycota/chemistry , Molecular Structure
11.
Eur J Med Chem ; 244: 114813, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36219902

ABSTRACT

In search of novel osteogenic entities, a series of twenty-seven quinazolinone-benzopyran-indole hybrids were designed and synthesized using molecular hybridization approach. All the compounds were scrutinized for their osteogenic potential, primarily based on alkaline phosphatase assay as one of the major anabolic markers. From the primary screening, four osteogenic compounds were sorted from the series and were found nontoxic to the osteoblasts. Further, increased osteoblast differentiation and osteogenic mRNA upregulations suggest compound 47 as the most potent osteoanabolic agent. Immunoblot and ELISA analysis demonstrated that compound 47 promotes osteogenesis via RUNX2 and BMP2 mediated non-canonical p38 pathway. In vivo studies in BALB/c mice inferred that compound 47 stimulates bone anabolism as evident from histological and gene expression studies at 5 mg. kg-1. day-1 dose. Furthermore, structural activity relationship (SAR) and pharmacokinetic studies suggest compound 47 as a BMP2 upregulator and a potential bone anabolic lead for combating future bone metabolic disorders.


Subject(s)
Benzopyrans , Osteogenesis , Mice , Animals , Up-Regulation , Benzopyrans/metabolism , Quinazolinones/pharmacology , Quinazolinones/metabolism , Bone Morphogenetic Protein 2/metabolism , Osteoblasts/metabolism , Indoles/metabolism , Cell Differentiation
12.
Molecules ; 27(18)2022 Sep 14.
Article in English | MEDLINE | ID: mdl-36144705

ABSTRACT

Marine sponges continue to attract remarkable attention as one of the richest pools of bioactive metabolites in the marine environment. The genus Smenospongia (order Dictyoceratida, family Thorectidae) sponges can produce diverse classes of metabolites with unique and unusual chemical skeletons, including terpenoids (sesqui-, di-, and sesterterpenoids), indole alkaloids, aplysinopsins, bisspiroimidazolidinones, chromenes, γ-pyrones, phenyl alkenes, naphthoquinones, and polyketides that possessed diversified bioactivities. This review provided an overview of the reported metabolites from Smenospongia sponges, including their biosynthesis, synthesis, and bioactivities in the period from 1980 to June 2022. The structural characteristics and diverse bioactivities of these metabolites could attract a great deal of attention from natural-product chemists and pharmaceuticals seeking to develop these metabolites into medicine for the treatment and prevention of certain health concerns.


Subject(s)
Biological Products , Naphthoquinones , Polyketides , Porifera , Alkenes/metabolism , Animals , Benzopyrans/metabolism , Biological Products/chemistry , Indole Alkaloids/chemistry , Naphthoquinones/metabolism , Pharmaceutical Preparations/metabolism , Polyketides/metabolism , Porifera/chemistry , Pyrones/metabolism , Terpenes/metabolism , Terpenes/pharmacology
13.
Appl Biochem Biotechnol ; 194(12): 5702-5716, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35802237

ABSTRACT

Monascus species are the producers of Monascus azaphilone pigments (MonAzPs) and lipid-lowering component Monacolin K, which have been widely used as food colorant and health products. In this study, silent information regulator 2 (Sir2) homolog (MrSir2) was characterized, and its impacts on the development and MonAzPs production of Monascus ruber were evaluated. Enzyme activity test in vitro showed that MrSir2 was an NAD+-dependent histone deacetylase. Compared to WT, Δmrsir2 strain accumulated more acetylated lysine residues of histone H3 subunit during its vegetative growth phase, and it exhibited accelerated mycelial aging, more spores, increased resistance to oxidative stress, and more MonAzPs production. RNA-Seq-based transcriptome analysis revealed that MrSir2 mainly regulated the gene expression in macromolecular metabolism such as carbohydrates, proteins, and nucleotides, as well as genes encoding cell wall synthesis and cell membrane component, indicating that MrSir2 probably facilitates the metabolic transition from the primary growth phase to the mycelial aging. Taken together, MrSir2 mainly targets H3 subunit at the vegetative growth phase and affects the development of M. ruber and MonAzPs production.


Subject(s)
Monascus , Monascus/metabolism , Pigments, Biological , Benzopyrans/metabolism
14.
Sci Rep ; 12(1): 203, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34997073

ABSTRACT

Burkholderia pseudomallei is a saprophytic bacterium endemic throughout the tropics causing severe disease in humans and animals. Environmental signals such as the accumulation of inorganic ions mediates the biofilm forming capabilities and survival of B. pseudomallei. We have previously shown that B. pseudomallei responds to nitrate and nitrite by inhibiting biofilm formation and altering cyclic di-GMP signaling. To better understand the roles of nitrate-sensing in the biofilm inhibitory phenotype of B. pseudomallei, we created in-frame deletions of narX (Bp1026b_I1014) and narL (Bp1026b_I1013), which are adjacent components of a conserved nitrate-sensing two-component system. We observed transcriptional downregulation in key components of the biofilm matrix in response to nitrate and nitrite. Some of the most differentially expressed genes were nonribosomal peptide synthases (NRPS) and/or polyketide synthases (PKS) encoding the proteins for the biosynthesis of bactobolin, malleilactone, and syrbactin, and an uncharacterized cryptic NRPS biosynthetic cluster. RNA expression patterns were reversed in ∆narX and ∆narL mutants, suggesting that nitrate sensing is an important checkpoint for regulating the diverse metabolic changes occurring in the biofilm inhibitory phenotype. Moreover, in a macrophage model of infection, ∆narX and ∆narL mutants were attenuated in intracellular replication, suggesting that nitrate sensing contributes to survival in the host.


Subject(s)
Bacterial Proteins/metabolism , Biofilms/growth & development , Biological Products/metabolism , Burkholderia pseudomallei/metabolism , Nitrates/metabolism , Nitrites/metabolism , Bacterial Proteins/genetics , Benzopyrans/metabolism , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/growth & development , Gene Expression Regulation, Bacterial , Host-Pathogen Interactions , Lactones/metabolism , Microbial Viability , Mutation , Transcription, Genetic
15.
Chem Biodivers ; 19(1): e202100599, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34786830

ABSTRACT

A new series of imino-2H-chromene derivatives were rationally designed and synthesized as novel multifunctional agents against Alzheimer's disease. A set of phenylimino-2H-chromenes as well as the newly synthesized iminochromene derivatives were evaluated as BACE1, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) inhibitors. The results indicated that among the iminochromene set, 10c bearing fluorobenzyl moiety was the most potent BACE1 inhibitor with an IC50 value 6.31 µM. In vitro anti-cholinergic activities demonstrated that compound 10a bearing benzyl pendant was the best inhibitor of AChE (% inhibition at 30 µM=24.4) and BuChE (IC50 =3.3 µM). Kinetic analysis of compound 10a against BuChE was also performed and showed a mixed-type inhibition pattern. The neuroprotective assessment revealed that compound 11b, a phenylimino-2H-chromene derivative with hydroxyethyl moiety, provided 32.3 % protection at 25 µM against Aß-induced PC12 neuronal cell damage. In addition, docking and simulation studies of the most potent compounds against BACE1 and BuChE confirmed the experimental results.


Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Benzopyrans/chemistry , Cholinesterase Inhibitors/chemical synthesis , Drug Design , Neuroprotective Agents/metabolism , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Alzheimer Disease/drug therapy , Alzheimer Disease/pathology , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Animals , Apoptosis/drug effects , Benzopyrans/metabolism , Benzopyrans/pharmacology , Benzopyrans/therapeutic use , Binding Sites , Butyrylcholinesterase/chemistry , Butyrylcholinesterase/metabolism , Catalytic Domain , Cholinesterase Inhibitors/metabolism , Cholinesterase Inhibitors/pharmacology , Cholinesterase Inhibitors/therapeutic use , Drug Evaluation, Preclinical , Kinetics , Molecular Docking Simulation , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/chemistry , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , PC12 Cells , Rats
16.
J Enzyme Inhib Med Chem ; 36(1): 1798-1809, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34348556

ABSTRACT

Identifying isoform-specific inhibitors for closely related kinase family members remains a substantial challenge. The necessity for achieving this specificity is exemplified by the RSK family, downstream effectors of ERK1/2, which have divergent physiological effects. The natural product, SL0101, a flavonoid glycoside, binds specifically to RSK1/2 through a binding pocket generated by an extensive conformational rearrangement within the RSK N-terminal kinase domain (NTKD). In modelling experiments a single amino acid that is divergent in RSK3/4 most likely prevents the required conformational rearrangement necessary for SL0101 binding. Kinetic analysis of RSK2 association with SL0101 and its derivatives identified that regions outside of the NTKD contribute to stable inhibitor binding. An analogue with an n-propyl-carbamate at the 4" position on the rhamnose moiety was identified that forms a highly stable inhibitor complex with RSK2 but not with RSK1. These results identify a SL0101 modification that will aid the identification of RSK2 specific inhibitors.


Subject(s)
Benzopyrans/chemical synthesis , Monosaccharides/chemical synthesis , Protein Kinase Inhibitors/chemical synthesis , Ribosomal Protein S6 Kinases, 90-kDa/antagonists & inhibitors , Amino Acid Sequence , Benzopyrans/metabolism , Carbamates/chemistry , Humans , Kinetics , Models, Molecular , Monosaccharides/metabolism , Protein Binding , Protein Conformation , Protein Kinase Inhibitors/metabolism , Rhamnose/chemistry , Ribosomal Protein S6 Kinases, 90-kDa/genetics , Structure-Activity Relationship
17.
Molecules ; 26(12)2021 Jun 16.
Article in English | MEDLINE | ID: mdl-34208750

ABSTRACT

Entamoeba histolytica (protozoan; family Endomoebidae) is the cause of amoebiasis, a disease related to high morbidity and mortality. Nowadays, this illness is considered a significant public health issue in developing countries. In addition, parasite resistance to conventional medicinal treatment has increased in recent years. Traditional medicine around the world represents a valuable source of alternative treatment for many parasite diseases. In a previous paper, we communicated about the antiprotozoal activity in vitro of the methanolic (MeOH) extract of Ruta chalepensis (Rutaceae) against E. histolytica. The plant is extensively employed in Mexican traditional medicine. The following workup of the MeOH extract of R. chalepensis afforded the furocoumarins rutamarin (1) and chalepin (2), which showed high antiprotozoal activity on Entamoeba histolytica trophozoites employing in vitro tests (IC50 values of 6.52 and 28.95 µg/mL, respectively). Therefore, we offer a full scientific report about the bioguided isolation and the amebicide activity of chalepin and rutamarin.


Subject(s)
Furocoumarins/isolation & purification , Ruta/metabolism , Amebicides/isolation & purification , Amebicides/pharmacology , Antiprotozoal Agents/pharmacology , Benzopyrans/metabolism , Entamoeba histolytica/drug effects , Entamoeba histolytica/pathogenicity , Furocoumarins/pharmacology , Inhibitory Concentration 50 , Medicine, Traditional , Mexico , Plant Extracts/isolation & purification , Plant Extracts/pharmacology
18.
Eur J Med Chem ; 223: 113658, 2021 Nov 05.
Article in English | MEDLINE | ID: mdl-34175542

ABSTRACT

Opioid analgesics are highly effective painkillers for the treatment of moderate or severe pain, but they are associated with a number of undesirable adverse effects, including the development of tolerance, addiction, constipation and life-threatening respiratory depression. The development of new and safer analgesics with innovative mechanisms of action, which can enhance the efficacy in comparison to available treatments and reduce their side effects, is urgently needed. The sigma-1 receptor (σ1R), a unique Ca2+-sensing chaperone protein, is expressed throughout pain-modulating tissues and affects neurotransmission by interacting with different protein partners, including molecular targets that participate in nociceptive signalling, such as the µ-opioid receptor (MOR), N-methyl-d-aspartate receptor (NMDAR) and cannabinoid 1 receptor (CB1R). Overwhelming pharmacological and genetic evidence indicates that σ1R antagonists induce anti-hypersensitive effects in sensitising pain conditions (e.g. chemically induced, inflammatory and neuropathic pain) and enhance opioid analgesia but not opioid-mediated detrimental effects. It has been suggested that balanced modulation of MORs and σ1Rs may improve both the therapeutic efficacy and safety of opioids. This review summarises the functional profiles of ligands with mixed MOR agonist and σ1R antagonist activities and highlights their therapeutic potentials for pain management. Dual MOR agonism/σ1R antagonism represents a promising avenue for the development of potent and safer analgesics.


Subject(s)
Analgesics, Opioid/chemistry , Receptors, Opioid, delta/antagonists & inhibitors , Receptors, Opioid, mu/agonists , Analgesics, Opioid/adverse effects , Analgesics, Opioid/metabolism , Analgesics, Opioid/therapeutic use , Benzopyrans/chemistry , Benzopyrans/metabolism , Humans , Ligands , Pain/drug therapy , Piperazines/chemistry , Piperazines/metabolism , Receptors, Opioid, delta/metabolism , Receptors, Opioid, mu/metabolism , Receptors, sigma/antagonists & inhibitors , Receptors, sigma/metabolism , Sigma-1 Receptor
19.
Eur J Med Chem ; 222: 113603, 2021 Oct 15.
Article in English | MEDLINE | ID: mdl-34126456

ABSTRACT

We reported three distinct series of novel benzothiopyranones, derived from an active metabolite (M-1) of anti-TB agent 6b. These small molecules were evaluated for their biological activities against a range of Mycobacterium tuberculosis (M. tuberculosis) strains. Preliminary druggability evaluation demonstrated that M-1 showed good aqueous solubility and hepatocyte stability. Benzothiopyranones with acyl, sulfonyl and phosphoryl groups exhibited potent in vitro inhibitory activity against M. tuberculosis H37Rv and low cytotoxicity. In particular, compound 3d, containing a benzoate fragment, displayed marked metabolic stability and potent in vitro activity against drug-resistant tuberculosis clinical strains. Further druggability evaluation based on the identified compounds 3d, 4e and 5b is ongoing for the discovery of promising anti-TB agents.


Subject(s)
Amides/pharmacology , Antitubercular Agents/pharmacology , Benzopyrans/pharmacology , Esters/pharmacology , Mycobacterium tuberculosis/drug effects , Amides/chemistry , Amides/metabolism , Antitubercular Agents/chemistry , Antitubercular Agents/metabolism , Benzopyrans/chemistry , Benzopyrans/metabolism , Dose-Response Relationship, Drug , Esters/chemistry , Esters/metabolism , Microbial Sensitivity Tests , Molecular Structure , Structure-Activity Relationship
20.
Cell Chem Biol ; 28(10): 1489-1500.e8, 2021 10 21.
Article in English | MEDLINE | ID: mdl-33989565

ABSTRACT

Vitamin E exhibits pharmacological effects beyond established antioxidant activity suggesting involvement of unidentified mechanisms. Here, we characterize endogenously formed tocopherol carboxylates and the vitamin E mimetic garcinoic acid (GA) as activators of the peroxisome proliferator-activated receptor gamma (PPARγ). Co-stimulation of PPARγ with GA and the orthosteric agonist pioglitazone resulted in additive transcriptional activity. In line with this, the PPARγ-GA complex adopted a fully active conformation and interestingly contained two bound GA molecules with one at an allosteric site. A co-regulator interaction scan demonstrated an unanticipated co-factor recruitment profile for GA-bound PPARγ compared with canonical PPARγ agonists and gene expression analysis revealed different effects of GA and pioglitazone on PPAR signaling in hepatocytes. These observations reveal allosteric mechanisms of PPARγ modulation as an alternative avenue to PPARγ targeting and suggest contributions of PPARγ activation by α-13-tocopherolcarboxylate to the pharmacological effects of vitamin E.


Subject(s)
PPAR gamma/metabolism , Vitamin E/metabolism , Allosteric Regulation/drug effects , Animals , Benzopyrans/chemistry , Benzopyrans/metabolism , Binding Sites , Crystallography, X-Ray , Hep G2 Cells , Humans , Ligands , Molecular Dynamics Simulation , PPAR gamma/agonists , Pioglitazone/chemistry , Pioglitazone/metabolism , Protein Binding , Receptors, Cytoplasmic and Nuclear/chemistry , Receptors, Cytoplasmic and Nuclear/metabolism , Signal Transduction/drug effects , Transcriptome/drug effects , Vitamin E/chemistry , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL